Christopher C. Benz
Impact in
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 58
- Breast Cancer Treatment Studies 17
- Oncology 80
- HER2/EGFR in Cancer Research 32
- Cancer-related Molecular Pathways 18
- Co-authors
- Gary K. Scott (55 shared papers)Dmitri B. Kirpotin (23 shared papers)John W. Park (24 shared papers)Keelung Hong (19 shared papers)Christina S. F. Yau (27 shared papers)Daryl C. Drummond (11 shared papers)James D. Marks (12 shared papers)Debu Tripathy (5 shared papers)
- Journals
- Cell (15 papers)Breast Cancer Research and Treatment (15 papers)Cell Reports (13 papers)Nature (12 papers)Nature Communications (11 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Christopher C. Benz
277 papers receiving 76.2k citations
Christopher C. Benz's Hit Papers
Peers
Comparison fields: 5 of 189
- Cancer Research 23.9k
- Oncology 19.4k
- Molecular Biology 38.6k
- Pulmonary and Respiratory Medicine 13.6k
- Genetics 4.6k
Countries citing papers authored by Christopher C. Benz
This map shows the geographic impact of Christopher C. Benz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Benz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Benz more than expected).
Fields of papers citing papers by Christopher C. Benz
This network shows the impact of papers produced by Christopher C. Benz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Benz. The network helps show where Christopher C. Benz may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher C. Benz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 2 | Comprehensive molecular profiling of lung adenocarcinoma Hit paper breakdown → | 2014 | 4550 |
| 3 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 4 | Comprehensive genomic characterization of squamous cell lung cancers Hit paper breakdown → | 2012 | 3290 |
| 5 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 6 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 7 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 8 | Comprehensive molecular characterization of urothelial bladder carcinoma Hit paper breakdown → | 2014 | 2419 |
| 9 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 10 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 11 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 12 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Hit paper breakdown → | 2017 | 1970 |
| 13 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 14 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 15 | Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma Hit paper breakdown → | 2016 | 1643 |
| 16 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 17 | Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer Hit paper breakdown → | 2015 | 1471 |
| 18 | Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Hit paper breakdown → | 1996 | 1186 |
| 19 | Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Hit paper breakdown → | 2006 | 961 |
| 20 | MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation Hit paper breakdown → | 2015 | 956 |
About Christopher C. Benz
Christopher C. Benz is a scholar working on Cancer Research, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 279 papers that have together received 77.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (58 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), HER2/EGFR in Cancer Research (32 papers), Estrogen and related hormone effects (25 papers), RNA modifications and cancer (20 papers), Cancer-related Molecular Pathways (18 papers), Breast Cancer Treatment Studies (17 papers) and Genomics and Chromatin Dynamics (15 papers). The work is most often cited by research in Cancer Research (23.9k citations), Oncology (19.4k citations), Molecular Biology (38.6k citations), Pulmonary and Respiratory Medicine (13.6k citations) and Genetics (4.6k citations). Christopher C. Benz has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Gary K. Scott, Dmitri B. Kirpotin, John W. Park, Keelung Hong, Christina S. F. Yau, Daryl C. Drummond, James D. Marks, Debu Tripathy, Ulrik B. Nielsen and Dan H. Moore. Their work appears in journals such as Cell, Breast Cancer Research and Treatment, Cell Reports, Nature and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.